CheckMate-214 trial results show longer treatment-free survival with immunotherapy
Cancer
.
2022 Mar 15;128(6):1156.
doi: 10.1002/cncr.34139.
Author
Kate O'Rourke
PMID:
35218211
DOI:
10.1002/cncr.34139
No abstract available
Publication types
News
MeSH terms
Clinical Trials as Topic*
Disease-Free Survival
Humans
Immunotherapy*
Treatment Outcome